Bradykinin and cardiac protection.
Gohlke
P
P
Department of Pharmacology, University of Kiel, Germany.
Tschöpe
C
C
Unger
T
T
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D001920:Bradykinin / Q000494:pharmacology* / Q000502:physiology*; D002316:Cardiotonic Agents; D003331:Coronary Vessels / Q000502:physiology; D006321:Heart / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000503:physiopathology; D017379:Hypertrophy, Left Ventricular / Q000503:physiopathology; D009203:Myocardial Infarction / Q000201:enzymology; D017202:Myocardial Ischemia / Q000201:enzymology; D007703:Peptidyl-Dipeptidase A / Q000378:metabolism*
D000806:Angiotensin-Converting Enzyme Inhibitors; D002316:Cardiotonic Agents; D007703:Peptidyl-Dipeptidase A; D001920:Bradykinin